Clinicopathological correlation of radiologic measurement of post-therapy tumor size and tumor volume for pancreatic ductal adenocarcinoma
- 14 November 2020
- journal article
- research article
- Published by Elsevier in Pancreatology
- Vol. 21 (1) , 200-207
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 29 references indexed in Scilit:
- Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice GuidelineJournal of Clinical Oncology, 2016
- Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinomaCancer, 2016
- Demographics, Epidemiology, and Inheritance of Pancreatic Ductal AdenocarcinomaSeminars in Oncology, 2015
- Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancerPhysical Biology, 2014
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United StatesCancer Research, 2014
- Transport properties of pancreatic cancer describe gemcitabine delivery and responseJournal of Clinical Investigation, 2014
- Can positron emission tomography-computed tomography predict response in locally advanced rectal cancer patients treated with induction folinic acid and 5-florouracil?Indian Journal of Cancer, 2014
- Effect of Neoadjuvant Chemoradiation and Surgical Technique on Recurrence of Localized Pancreatic CancerJournal of Gastrointestinal Surgery, 2011
- Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinomaCancer, 2011
- Pancreatic Cancer: Basic and Clinical AspectsGastroenterology, 2005